Work

Abstract P2-16-07: hMMP9 as Predictive Factor for Response and Progression Free Survival in Breast Cancer Patients Treated with Bevacizumab and Pegylated Liposomal Doxorubicin (PLD)

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs10-p2-16-07

Authors: K Zaman, C Rochlitz, T Ruhstaller, B Thürlimann, S Aebi, R von Moos, C Mamot, N Gabriel, L Rossier-Pansier, R Stupp, S Crowe, C. Ruegg

Institutions: Kantonsspital St. Gallen, University Hospital of Bern, Centre Hospitalier Universitaire Vaudois, University Hospital of Basel, University Hospital Zurich, Swiss Group For Clinical Cancer Research, Kantonsspital Graubünden, Kantonsspital Aarau

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2028001096

Cites:

Cited by:

Related to: 10